Cite
HARVARD Citation
Sakata, K. et al. (n.d.). Efficacy of alogliptin, a dipeptidyl peptidase‐4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) – receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes. Diabetes/metabolism research and reviews. 29 (8), pp. 624-630. [Online].